Clint was a rock climber, a multiple sclerosis (MS) patient, and future doctor. He didn’t need anyone. Ursula, a survivor of South Africa’s apartheid, mesmerized Clint, and their marriage seemed inevitable. When Clint’s MS worsened, making climbing dangerous, Ursula helped teach him to climb mountains of a different kind. Falling Clint and Ursula Pearson Book Trailer Find out more about this author here http://www.fallingdoc.com/
Find out more about this book http://tinyurl.com/ya382td Genre: Non-Fiction
The American Society for Aesthetic Plastic Surgery (ASAPS), is hosting a panel discussion about the latest best practices and uses for injectables including the newest FDA-approved options at The Aesthetic Meeting today in Montreal, Quebec Canada.
The panel discussed the latest advances, including the ways various dermal fillers can be utilized to produce optimal results for targeted areas. There are thirteen FDA-approved dermal fillers on the market to-date, providing aesthetic plastic surgeons with the ability to customize anti-aging treatments to patients’ needs. “The filler choices are dictated by a patient’s unique aging pattern, the anatomical area to be treated and physiochemical properties,” explains ASAPS member, Dr. Z. Paul Lorenc.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7310753-asaps-facial-rejuvenation-injectables/
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
By reprogramming a 7–year–old girl’s own immune cells to attack an aggressive form of childhood leukemia, a pediatric oncologist has achieved a complete response in his patient, who faced grim prospects when she relapsed after conventional treatment. The innovative experimental therapy used bioengineered T cells, custom–designed to multiply rapidly in the patient, and then destroy leukemia cells. After the treatment, the child’s doctors found that she had no evidence of cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/50777-chop-engineered-immune-t-cell-therapy-anticancer-effect-in-children
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced a collaboration with Atigeo™, a compassionate technology company that turns science into products and services for a wiser world. Together, Emdeon and Atigeo plan to explore the use of intelligent analytics layered on top of petabytes of healthcare data to improve health outcomes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59755-emdeon-and-atigeo-intelligent-analytics-for-health-outcomes-himss13
During a live global event, Elekta announced the launch of Versa HD™, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of cancers. Featuring high precision beam shaping and tumor targeting, Versa HD also unveils new capabilities designed to maximize health care system resources and deliver highly sophisticated therapies without compromising treatment times.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60246-elekta-sets-new-benchmark-for-cancer-treatment-launch-of-versa-hd-system
The vast majority of Americans say what they want at the end of life is to die in their own homes, as comfortable and pain-free as possible. The hospice philosophy is about making sure that a patient's death experience reflects their wishes by supporting one's life to the fullest dignity, regardless how much time remains. In fact, in many cases patients' quality of life can actually improve when they are admitted to hospice at the appropriate time.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7429131-moments-of-life-by-hospice/
dr samit sekhar - Indian Surrogacy : Executive Director of Kiran Infertility Centre Pvt. Ltd.(KIC), he also holds positions of IVF and Surrogacy Program Director , Director- Supra Sperm Semen Bank and is also the Chief Embryologist in KIC. With an experience of more than 5 Years in the field of Infertility, he has treated a clientele of more than 2000 IVF/ ICSI Patients and 800 Surrogacy Patients from 21 different countries. In charge of the overall maintenance of the IVF lab he is also involved in day to day patient interaction and counseling He passed his Bachelors in medicine in distinction. His expertise includes In-Vitro Fertilization (IVF), Intra Cytoplasm Sperm Injection (ICSI), Embryo Freezing (Vitrification), Semen Banking (Semen Freezing) and PIGD (Pre-Implanation Genetic Diagnosis). Dr. Samit has been instrumental in bringing India on the Medical Tourism World Map as Surrogacy Capital of world. Under his leadership there have been 221 births through Surrogacy Program in KIC for Intended Parents of 17 different countries. Different from what people imagine a Doctor should be. love to live life on my own terms, I think out of the box.
For the millions who suffer from Gastroesophageal Reflux Disease (GERD), a study published today in the New England Journal of Medicine (NEJM) provides clinical evidence of safety and effectiveness for a new, FDA-approved medical device. Torax Medical’s LINX® Reflux Management System was studied in a controlled, prospective, multicenter trial involving 14 U.S. and European medical centers as part of the FDA pre-market approval process. The patients were evaluated before and after treatment to determine the effect of the LINX System on their GERD using pre-defined success criteria, which included reduction of esophageal acid, improvement in quality of life and elimination of reflux medications.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60077-torax-medical-linx-reflux-management-system-clinical-study-published
The following statement is being issued by Jonathan Schochor, Chairman, Plaintiffs’ Steering Committee, regarding Jane Doe No. 1, et. al. v. Johns Hopkins Hospital, et al., No. 24-C-13-001041.
If you were a patient of, or treated by Johns Hopkins Hospital gynecologist, Dr. Nikita Levy, you are a member of a mandatory settlement class action.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65136-dr-nikita-levy-class-action-lawsuit-johns-hopkins-hospital-gynecology
The following statement is being issued by Jonathan Schochor, Chairman, Plaintiffs’ Steering Committee, regarding Jane Doe No. 1, et. al. v. Johns Hopkins Hospital, et al., No. 24-C-13-001041.
If you were a patient of, or were treated by Johns Hopkins Hospital gynecologist, Dr. Nikita Levy, you may be eligible for compensation from a class action Settlement
A $190 million dollar proposed Settlement has been reached that offers payments to eligible members of The Levy Settlement Class.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7281851-dr-nikita-levy-patients-class-action-settlement/
The Kiran Infertility Centre- KIC is a Super Specialty Facility dealing in Infertility Treatments & Surrogacy. An ISO 9001- 2008 Company, KIC with its cutting-edge technology, world-renowned experts and a patient-centric approach, has been a dominant player in the area of Fertility Treatments and is one of the oldest facilities in India offering Infertility Treatment. Dr Sekhar Samit